Ignite Creation Date:
2025-12-24 @ 7:38 PM
Ignite Modification Date:
2025-12-25 @ 5:19 PM
Study NCT ID:
NCT04503603
Status:
COMPLETED
Last Update Posted:
2022-03-07
First Post:
2020-08-05
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study to Determine the Safety, Tolerability, and Pharmacokinetics of Lanadelumab Administered Intravenously in Healthy Adult Volunteer Participants
Sponsor:
Takeda
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-10
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-23
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-05
First Submit QC Date:
None
Study First Post Date:
2020-08-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-12-14
Results First Submit QC Date:
None
Results First Post Date:
2022-03-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-14
Last Update Post Date:
2022-03-07
Last Update Post Date Type:
ACTUAL